Fabiano N, Zhou C, Wong S, Correll CU, et al. Switching to a muscarinic agonist to alleviate antipsychotic-induced metabolic and neuromotor adverse effects in a person living with schizophrenia. J Psychiatry Neurosci 2025;50:E200-E201.
PMID: 40610041